These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 76257)

  • 1. Identity of specific macrophage-active human lymphokines.
    Block LH; Jaksche H; Bamberger S; Ruhenstroth-Bauer G
    Lancet; 1978 Apr; 1(8066):718-9. PubMed ID: 76257
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences between macrophage migration inhibitions by lymphokines and muramyl dipeptide (MDP) or lipopolysaccharide (LPS): migration enhancement by lymphokines.
    Nagao S; Tanaka A; Onozaki K; Hashimoto T
    Cell Immunol; 1982 Jul; 71(1):1-11. PubMed ID: 6754096
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lymphokines, with special reference to skin reactive factor (SRF) (author's transl)].
    Aoki T
    Rinsho Byori; 1981 Dec; 29(12):1223-7. PubMed ID: 7040741
    [No Abstract]   [Full Text] [Related]  

  • 4. [The mechanism of the in vitro migration inhibition test (author's transl)].
    Sabioncello A; Dekaris D
    Lijec Vjesn; 1978 Sep; 100(9):535-42. PubMed ID: 368478
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of Lotus-tetragonolobus Lectin (LTL) and an MIF-like factor with guinea-pig macrophages. I. Effects on macrophage migration inhibition and receptor-binding studies.
    Fahlbusch B; Wollweber L; Drössler K; Scherbaum I; Zschiesche W
    Immunobiology; 1982 Aug; 162(3):251-64. PubMed ID: 6752005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical significance of macrophage electrophoretic mobility (MEM) test in tumor immunity.
    Nakajima T; Isojima K; Iwaguchi T
    Cell Mol Biol Incl Cyto Enzymol; 1979; 25(5):355-61. PubMed ID: 394842
    [No Abstract]   [Full Text] [Related]  

  • 7. Production of an antibody against guinea pig MIF. II. Analysis of the antibody-reacting material using radiolabeled lymphokines.
    Onozaki K; Haga S; Miura K; Homma Y; Hashimoto T
    Cell Immunol; 1980 Oct; 55(2):465-75. PubMed ID: 7000379
    [No Abstract]   [Full Text] [Related]  

  • 8. Assay of human lymphokines in vitro. Evidence for a migration stimulation factor (MStF) which interferes with the macrophage migration inhibition assay.
    Aaskov JG; Anthony HM
    Aust J Exp Biol Med Sci; 1976 Dec; 54(6):527-39. PubMed ID: 800335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic control of lymphokine production as assessed by macrophage migration inhibition and lymphocyte proliferation.
    Waxman FJ; Hinrichs DJ; Maurer PH; Baram P
    Cell Immunol; 1980 Mar; 50(1):1-18. PubMed ID: 6994892
    [No Abstract]   [Full Text] [Related]  

  • 10. An ELISA method for quantitation of macrophage migration from agarose microdroplets.
    Peck R
    J Immunol Methods; 1983 Nov; 64(1-2):179-87. PubMed ID: 6358361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of autologous sera in some dermatoses on spontaneous migration of leukocytes and macrophages taken from mouse spleens.
    Miklaszewska M
    Mater Med Pol; 1978; 10(2):101-6. PubMed ID: 359946
    [No Abstract]   [Full Text] [Related]  

  • 12. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migration inhibition and stimulation factors produced from peripheral blood lymphocyte cultures of sensitised guinea pigs.
    Matsui Y; Oshima S
    Asian Pac J Allergy Immunol; 1985 Dec; 3(2):151-5. PubMed ID: 3907650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of antisera against guinea pig macrophage activating factor.
    Peck R; Talmadge K; Polak L
    Int Arch Allergy Appl Immunol; 1984; 75(4):361-7. PubMed ID: 6389371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental studies on tuberculin hypersensitivity--immunological significance of leucocyte migration inhibitory factor (LIF) and macrophage migration inhibitory factor (MIF) (author's transl)].
    Matsui Y; Oshima S
    Kekkaku; 1979 Jun; 54(6):331-44. PubMed ID: 388018
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrophage-directed lymphokines.
    Liu DY
    Surv Immunol Res; 1984; 3(2-3):154-60. PubMed ID: 6426009
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphocyte-derived factors affecting cell migration in vitro.
    Bergstrand H
    Allergy; 1979 Apr; 34(2):69-96. PubMed ID: 382903
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphokines and macrophages.
    David JR; Remold HG; Liu DY; Weiser WY; David RA
    Cell Immunol; 1983 Nov; 82(1):75-81. PubMed ID: 6416686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.